EP0728010A4 - Method for treating hepatitis b carriers with minimal disease - Google Patents

Method for treating hepatitis b carriers with minimal disease

Info

Publication number
EP0728010A4
EP0728010A4 EP93925097A EP93925097A EP0728010A4 EP 0728010 A4 EP0728010 A4 EP 0728010A4 EP 93925097 A EP93925097 A EP 93925097A EP 93925097 A EP93925097 A EP 93925097A EP 0728010 A4 EP0728010 A4 EP 0728010A4
Authority
EP
European Patent Office
Prior art keywords
carriers
treating hepatitis
minimal disease
minimal
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93925097A
Other languages
German (de)
French (fr)
Other versions
EP0728010A1 (en
Inventor
Bruce F Scharschmidt
John D Baxter
David L Horwitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sciclone Pharmaceuticals LLC
Original Assignee
Sciclone Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/833,468 external-priority patent/US5308833A/en
Application filed by Sciclone Pharmaceuticals LLC filed Critical Sciclone Pharmaceuticals LLC
Publication of EP0728010A1 publication Critical patent/EP0728010A1/en
Publication of EP0728010A4 publication Critical patent/EP0728010A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP93925097A 1992-02-06 1993-10-28 Method for treating hepatitis b carriers with minimal disease Withdrawn EP0728010A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/833,468 US5308833A (en) 1992-02-06 1992-02-06 Method for treating hepatitis B carriers with minimal disease
PCT/US1993/010343 WO1995011688A1 (en) 1992-02-06 1993-10-28 Method for treating hepatitis b carriers with minimal disease

Publications (2)

Publication Number Publication Date
EP0728010A1 EP0728010A1 (en) 1996-08-28
EP0728010A4 true EP0728010A4 (en) 1997-10-01

Family

ID=1340654

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93925097A Withdrawn EP0728010A4 (en) 1992-02-06 1993-10-28 Method for treating hepatitis b carriers with minimal disease

Country Status (5)

Country Link
EP (1) EP0728010A4 (en)
NO (1) NO961685D0 (en)
SG (1) SG64892A1 (en)
TW (1) TW249755B (en)
WO (1) WO1995011688A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332982T2 (en) * 1993-11-05 2004-09-09 Alpha 1 Biomedicals, Inc. COMPOSITIONS CONTAINING THYMOSIN-ALPHA-1 FOR TREATING HEPATITIS B IN PATIENTS WITH DECOMPENSED LIVER DISEASE

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005806A1 (en) * 1991-09-13 1993-04-01 Alpha 1 Biomedicals, Inc. Composition and method of treating hepatitis c
US5308833A (en) * 1992-02-06 1994-05-03 Sciclone Pharmaceuticals Method for treating hepatitis B carriers with minimal disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005806A1 (en) * 1991-09-13 1993-04-01 Alpha 1 Biomedicals, Inc. Composition and method of treating hepatitis c
US5308833A (en) * 1992-02-06 1994-05-03 Sciclone Pharmaceuticals Method for treating hepatitis B carriers with minimal disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIOLOGICAL ABSTRACTS, vol. 92, no. 11, 1991, Philadelphia, PA, US; abstract no. 121545, M.G. MUTCHNICK ET AL.: "THYMOSIN TREATMENT OF CHRONIC HEPATITIS B: A PLACEBO-CONTROLLED PILOT TRIAL." page 229; XP002036518 *
HEPATOLOGY, vol. 14, no. 3, 1991, pages 409 - 415 *
See also references of WO9511688A1 *

Also Published As

Publication number Publication date
WO1995011688A1 (en) 1995-05-04
TW249755B (en) 1995-06-21
EP0728010A1 (en) 1996-08-28
NO961685L (en) 1996-04-26
SG64892A1 (en) 1999-05-25
NO961685D0 (en) 1996-04-26

Similar Documents

Publication Publication Date Title
EG19392A (en) Improved method for omprazole symthesis
GB9218346D0 (en) Process
AP9300593A0 (en) Process
HU9203682D0 (en) Methods for diagnosing and treating viral hepatitis
GB9203375D0 (en) Process
GB9009404D0 (en) Pelletisation process
GB9202375D0 (en) Process
SG64892A1 (en) Method for treating hepatitis b carriers with minimal disease
HU9300927D0 (en) Method for hetero-annulation
GB9220068D0 (en) Process
AP9300474A0 (en) Process
PH30891A (en) Method for treating hepatitis b carriers with minimal disease.
GB9215438D0 (en) Process
GB9201496D0 (en) Process
AP9300473A0 (en) Process
ZA938110B (en) Treatment of hepatitis B carriers with minimal disease
RU1785687C (en) Method for glossalgia treatment
IL104351A0 (en) Method for treating mycobacterial infections with rifabutin
GB9220526D0 (en) Process
HU9200586D0 (en) Poultry-breeding process for improving egg-production
GB9210926D0 (en) Nox removal process
GB9224659D0 (en) Nox removal process
GB9206425D0 (en) Carriers
GB9214518D0 (en) Carriers
IL123389A (en) Method for purifying trehalose

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960520

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19970819

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19990319

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990929